Natera Inc
(NAS:NTRA)
$
162.39
0.4 (0.25%)
Market Cap: 21.44 Bil
Enterprise Value: 20.99 Bil
PE Ratio: 0
PB Ratio: 22.95
GF Score: 70/100 Natera Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020 / 07:50PM GMT
Release Date Price:
$45.93
(+1.55%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Great. Welcome. This is Dan Brennan. I cover tools, diagnostics, pharma services here at UBS. Day 1 of our virtual conference. So thanks for anyone on the phone or on the webcast participating. Really pleased to be joined with me -- on the phone with the Chief Financial Officer of Natera, Mike Brophy. Mike and I actually go way back, having overlapped at a predecessor broker firm before Mike went on to greener pastures at Natera.
So Mike, welcome, and thanks for being with us.
Michael Brophy
Natera, Inc. - CFO
Thanks, Dan. It's good to be with you.
Questions & Answers
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Awesome. Well, feel free, anyone on the phone, to punch in some questions into the webcast. I will do my best. And we've gotten 1 or 2 each presentation, certainly, will do my best to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot